Impact of oral bisphosphonate drug holiday on mortality following hip fracture: a population-based cohort study

CONCLUSIONS: Post-fracture mortality is higher in people who discontinue risedronate, but not alendronate, for 1 or 2 years after being adherent to treatment for at least 5 years. The type of bisphosphonate may be a factor to consider when planning drug holidays.PMID:38630464 | DOI:10.1210/clinem/dgae272
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Source Type: research